Global Vascular Closure Device Market

Global Vascular Closure Device Market Size, Share, Growth Analysis, By Product Type(Active Approximators and Passive Approximators), By Access(Femoral Access and Radial Access) - Industry Forecast 2024-2031


Report ID: SQMIG35A2810 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 59 | Figures: 75

Global Vascular Closure Device Market Insights

Global Vascular Closure Device Market size was valued at USD 1.59 billion in 2022 and is poised to grow from USD 1.69 billion in 2023 to USD 2.80 billion by 2031, growing at a CAGR of 6.50% in the forecast period (2024-2031).

Vascular surgery stands at the forefront of ongoing developments in minimally invasive techniques. Among the widely employed diagnostic tools, angiograms play a pivotal role in medical disciplines like interventional cardiology, vascular surgery, and interventional radiology. The escalating prevalence of cardiovascular diseases, alongside a surge in cardiovascular patients, is poised to propel the industry forward. A consequential outcome of this trend is the heightened demand for vascular closure devices, facilitating an upswing in vascular catheterization procedures. The surge in valvular illnesses, myocardial infarction, and congenital heart diseases has propelled the popularity of angiographic procedures. These procedures, known for their ability to reduce bleeding and expedite recovery, often resort to manual compression at the access point. Despite the continued preference for manual compression, various vascular closure devices have been devised to aid surgeons in achieving efficient closure.

The growth trajectory of the vascular closure devices market is projected to be positively influenced by factors such as the increasing prevalence of cardiovascular diseases, a global uptick in heart surgeries, favorable reimbursement policies, and a heightened focus on managing blood loss during surgeries. Innovative technologies, categorized as vascular closure devices, have been developed to swiftly seal minor arterial punctures post-angiography. These devices offer a viable alternative to manual compression, facilitating rapid puncture sealing without the need for prolonged compression.

Biodegradable closure devices, characterized by their material composition that allows for natural healing through progressive disintegration, are witnessing a growing demand. The market is expected to expand further with an increasing inclination toward topical hemostatic medications and closure devices designed to enhance hemostasis. The segment of other indirect vascular closure devices is anticipated to experience growth, propelled by rising disposable incomes and heightened attention from market participants on large-bore vascular closure devices.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Vascular Closure Device Market size was valued at USD 1.59 billion in 2022 and is poised to grow from USD 1.69 billion in 2023 to USD 2.80 billion by 2031, growing at a CAGR of 6.50% in the forecast period (2024-2031).

The market exhibitions a moderate level of merging, with a handful of major players imposing a significant share of the revenue. These key industry participants are advantageously intent on the introduction of innovative products to support their market positioning. Additionally, their focus extends to performing strategic initiatives, including partnerships, product launches, and collaborations, enhancing their overall market presence. 'Abbott Laboratories', 'Terumo Corporation', 'Cardinal Health', 'Medtronic plc', 'Boston Scientific Corporation', 'Merit Medical Systems, Inc.', 'B. Braun Melsungen AG', 'Cook Medical', 'InSeal Medical', 'Marine Polymer Technologies, Inc.', 'Cardiva Medical, Inc.', 'Essential Medical, Inc.', 'Teleflex Incorporated', 'Vascular Solutions (Acquired by Teleflex)', 'Vivasure Medical Ltd.', 'Scion BioMedical', 'Transluminal Technologies', 'Morris Innovative, Inc.', 'TZ Medical, Inc.', 'Carden Jennings Publishing Co., Ltd.'

Cardiovascular diseases (CVDs) stand as a prominent global cause of mortality, contributing significantly to the overall death toll. According to data from the American Heart Association (AHA), CVDs accounted for 18.6 million deaths in 2019, with a notable concentration in Eastern Europe and Central Asia. The AHA further forecasts that by 2030, approximately 40.5% of the United States population is expected to experience some form of CVD. This escalating prevalence of cardiovascular diseases is poised to drive the demand for catheterization and interventional procedures aimed at diagnosing and treating CVDs. The growing popularity of these procedures is anticipated to be a key driver propelling the market for vascular closure devices in the forthcoming years.

A remarkable trend in the Vascular Closure Device market is the increasing importance of biodegradable closure devices. These innovative devices represent a significant leap in vascular interference technology by incorporating biodegradable materials that undergo progressive disintegration, promoting natural healing processes. Biodegradable closure devices offer distinct advantages, such as reducing the long-term presence of foreign materials within the body, mitigating potential complications associated with permanent implants. Their biocompatible nature aligns with the growing emphasis on patient safety and comfort. The demand for biodegradable closure devices is on the rise, driven by their ability to provide effective vascular closure while addressing concerns related to long-term implantation, making them a promising avenue for enhancing patient outcomes in minimally invasive vascular procedures.

In the year 2022, North America held a significant share in the vascular closure device market, recording revenues surpassing USD 689 million. The region is poised for sustained growth until 2032, primarily driven by the heightened prevalence of cardiovascular diseases. The expanding population of elderly individuals, who exhibit a greater susceptibility to cardiovascular ailments, has prompted the establishment of advanced healthcare infrastructure in the region. Furthermore, the presence of extensive reimbursement coverage for medical procedures acts as a compelling incentive for both healthcare professionals and patients. This, in turn, encourages the adoption of innovative treatment alternatives and contributes substantially to the overall progress and advancement of the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Vascular Closure Device Market

Product ID: SQMIG35A2810

$5,300
BUY NOW GET FREE SAMPLE